A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation

Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative option for progressive marrow failure, myelodysplastic syndrome, or leukemia associated with dyskeratosis congenita (DC). HSCT for DC is limited by a high incidence of treatment-related mortality, thought to be related to...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Biol Blood Marrow Transplant
Main Authors: Nelson, Adam S., Marsh, Rebecca A., Myers, Kasiani C., Davies, Stella M., Jodele, Sonata, O’Brien, Tracey A., Mehta, Parinda A.
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4826289/
https://ncbi.nlm.nih.gov/pubmed/26845033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.01.026
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker